Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells (Q58106726)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

S Lopez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B Bonardo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

I Juhan-Vague

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G Nalbone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

359-366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

New lipid lowering drugs and new effects of old drugs.

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Systematic review on the risk and benefit of different cholesterol-lowering interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Statins do more than just lower cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Direct vascular effects of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Effect of Fluvastatin on Lipids and Fibrinolysis in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900454-8

10.1016/S0021-9150(00)00454-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998463%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference